Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 72.60M P/E - EPS this Y - Ern Qtrly Grth -
Income -23.32M Forward P/E -3.74 EPS next Y - 50D Avg Chg -21.00%
Sales 32.8M PEG - EPS past 5Y -24.05% 200D Avg Chg -22.00%
Dividend N/A Price/Book 3.83 EPS next 5Y - 52W High Chg -47.00%
Recommedations - Quick Ratio 2.59 Shares Outstanding 51.23M 52W Low Chg 46.00%
Insider Own 24.19% ROA -16.53% Shares Float 39.35M Beta 0.75
Inst Own 39.58% ROE -45.01% Shares Shorted/Prior 733.14K/792.87K Price 1.46
Gross Margin 42.17% Profit Margin 99.28% Avg. Volume 256,006 Target Price -
Oper. Margin -25.55% Earnings Date Jun 12 Volume 165,104 Change 0.00%
About Enzo Biochem, Inc.

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Enzo Biochem, Inc. News
03/14/24 Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years ago
03/13/24 Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
02/01/24 Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
01/30/24 Here’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)
12/15/23 ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
11/06/23 ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
10/30/23 Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
10/06/23 Enzo Biochem (NYSE:ENZ) shareholders have endured a 63% loss from investing in the stock five years ago
09/06/23 Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
07/31/23 Here’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)
07/24/23 Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
06/14/23 Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
06/08/23 Enzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under Threat From Overpricing
05/22/23 Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
05/14/23 Enzo Biochem Insiders Added US$11m Of Stock To Their Holdings \
04/24/23 Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
04/17/23 Enzo Biochem (NYSE:ENZ) shareholders have endured a 58% loss from investing in the stock five years ago
ENZ Chatroom

User Image Stock_Titan Posted - 2 weeks ago

$ENZ Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update https://www.stocktitan.net/news/ENZ/enzo-biochem-reports-second-quarter-fiscal-2024-results-and-provides-2c72bkqahkcn.html

User Image Deadman3906 Posted - 2 weeks ago

$DJT $HELLO.X $FR $ENZ

User Image Captain516 Posted - 4 weeks ago

$ENZ this company is fucking doomed. They use and abuse their employees. Kara Shithead Cannon lines her pockets and treats her employees like shit. Ruined the life sciences division and then sold her employees off like cattle and then gave herself a raise and bonus. She can eat shit.

User Image NioUSD200 Posted - 1 month ago

$ENZ exited long ago. Just peeping to say hi to veterans

User Image TickerDD_com Posted - 1 month ago

From 2/16/2024, looking back across 22 Month-Ends for ENZ, Percentage Change of Average Monthly Price had More Negatives (68%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ENZ #ENZ #ENZStock #TickerDD #ENZPrice https://www.youtube.com/watch?v=nbq9Txb9bKY

User Image Chimeric Posted - 1 month ago

$ENZ . Drastically undervalued? Worth close to 3? Will higher prices ever be realized or is this a pipe dream? Long at 1.53 avg and been holding for several years.

User Image tickeron Posted - 2 months ago

If you’re trading this week, Read This! $ENZ price exceeded its 50-day Moving Average. View odds of downtrend. https://srnk.us/go/4976792

User Image BaugHouldir Posted - 2 months ago

$ENZ can alone explain what is going on here?

User Image tickeron Posted - 2 months ago

A.I.dvisor made a bullish call on $ENZ, netting in a 15.38% gain over 2 weeks https://srnk.us/go/4963483

User Image tickeron Posted - 2 months ago

What do you think of this? $ENZ price may drop as it broke higher Bollinger Band. View odds of downtrend. https://srnk.us/go/4959199

User Image cctranscripts Posted - 3 months ago

Revised definitive proxy soliciting materials https://www.conferencecalltranscripts.org/summary/?id=12815197 $ENZ

User Image cctranscripts Posted - 3 months ago

Enzo Biochem just filed its Annual Report to Security Holders http://www.sec.gov/Archives/edgar/data/316253/000114036123058917/0001140361-23-058917-index.htm $ENZ

User Image risenhoover Posted - 3 months ago

$ENZ / Enzo Biochem files form ARS https://fintel.io/doc/null?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Fullratio Posted - 3 months ago

$ENZ quick ratio has soared by 159% YoY and by 17% from the previous quarter: https://fullratio.com/stocks/nyse-enz/enzo-biochem

User Image tickeron Posted - 3 months ago

This is amazing! What do you think? $ENZ price moved above its 50-day Moving Average. View odds of downtrend. https://srnk.us/go/4943685

User Image tickeron Posted - 3 months ago

Does this make you nervous? $ENZ price moved above its 50-day Moving Average. View odds of downtrend. https://srnk.us/go/4942750

User Image STCKPRO Posted - 3 months ago

$ENZ NEW ARTICLE : ENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024 https://www.stck.pro/news/ENZ/70412910/

User Image Last10K Posted - 3 months ago

$ENZ just filed a 10-Q Quarterly Report with 7 financial statements and 51 disclosures: https://last10k.com/sec-filings/enz/0001213900-23-096093.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=enz

User Image Stock_Titan Posted - 3 months ago

$ENZ ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE https://www.stocktitan.net/news/ENZ/enzo-biochem-reports-first-quarter-fiscal-2024-results-and-provides-e5x94rh9fl15.html

User Image risenhoover Posted - 3 months ago

$ENZ / Enzo Biochem files form 10-Q https://fintel.io/doc/sec-enzo-biochem-inc-316253-10q-2023-december-15-19706-1860?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Ca1iman Posted - 3 months ago

$ENZ Im seeing an Earnings for monday in the calendar but not on the site and they had YE/Q on Nov. 6.

User Image stockcloud Posted - 3 months ago

$LLAP - Called earlier/today - nice study/returns. $GOTU $ENZ $ADCT $BPTS - Potential uptrend. TO watch list - GLTA:-)

User Image fin_researcher Posted - 11/30/23

$ENZ announced that it has entered into an agreement for Labcorp to acquire the assets of Enzo’s Clinical Laboratory division. In 2022, Enzo Biochem initiated a strategic initiative to restructure operations to target business areas and industry sectors representing major growth opportunities. Investors may have reasons to suspect $ENZ, its Leaders, and its Advisors of failing to act in the best interests of shareholders. To claim compensation: https://11thestate.com/cases/enzo-labcorp-case

User Image cctranscripts Posted - 3 months ago

Annual report [Section 13 and 15(d), not S-K Item 405] https://www.conferencecalltranscripts.org/summary/?id=12745362 $ENZ

User Image tickeron Posted - 4 months ago

What do you think of this? $ENZ MACD Histogram turned positive on November 24, 2023. View odds of downtrend. https://srnk.us/go/4924758

User Image TickerDD_com Posted - 4 months ago

$ENZ Short Interest for the 2-Week Period ending on 31-Oct-2023 #ENZ #shortinterest #usstock #StillStonkingOnThanksgiving https://www.youtube.com/watch?v=Or0iGkAQp4k

User Image Gj64 Posted - 4 months ago

$ENZ NBiO ERAS

User Image tickeron Posted - 4 months ago

Oh wow this is big! $ENZ price may climb as it broke lower Bollinger Band. View odds of downtrend. https://srnk.us/go/4911456

User Image Stock_Titan Posted - 4 months ago

$ENZ ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE https://www.stocktitan.net/news/ENZ/enzo-biochem-reports-fourth-quarter-and-fiscal-year-2023-results-and-sej3ql77ikzb.html

User Image Chimeric Posted - 4 months ago

$ENZ Dumped the 10k on a Friday night. States no dividend will be paid and also no news on any potential sale. Operating performance was flat….

Analyst Ratings
Craig-Hallum Buy Feb 4, 14
Sidoti & Co. Neutral Jul 2, 13
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wolf James G. Other Other Feb 10 Buy 1.29 15,000 19,350 115,000 02/13/23
Wolf James G. 10% Owner 10% Owner Jan 27 Buy 1.4 11,800 16,520 4,090,000 01/30/23
Wolf James G. 10% Owner 10% Owner Oct 31 Buy 2.15 23,000 49,450 418,500 01/19/23
Wolf James G. 10% Owner 10% Owner Oct 31 Buy 2.15 23,000 49,450 418,500 01/18/23
Erfanian Hamid Chief Executive Offi.. Chief Executive Officer Nov 23 Buy 1.97 100,000 197,000 374,600 11/28/22
Cannon Kara Chief Operating Offi.. Chief Operating Officer Jul 15 Buy 2.42 2,500 6,050 2,500 07/19/22
Radoff Bradley Louis Director Director Jul 12 Buy 2.27 12,500 28,375 4,194,663 07/13/22
Radoff Bradley Louis Director Director Jul 05 Buy 2.20 120,000 264,000 4,182,163 07/06/22
Radoff Bradley Louis Director Director Jun 15 Buy 2.21 125,000 276,250 3,987,163 06/16/22